Skip to main content
Figure 1 | BMC Systems Biology

Figure 1

From: Global network analysis of drug tolerance, mode of action and virulence in methicillin-resistant S. aureus

Figure 1

Sublethal exposure to ranalexin (iTRAQ). Growth is shown for duplicate samples of MRSA-252 cultured with 20 μgml-1 ranalexin (▲, Δ) and controls (■, □). Total CFU/ml is shown for ranalexin treated samples (○) and controls (●). Ranalexin treatment produces a temporary reduction of growth rate. Cells were harvested for proteome profiling by iTRAQ (Methods) at OD600 0.58, or one hour after ranalexin addition.

Back to article page

BMC Systems Biology

ISSN: 1752-0509

Contact us